David Gionco

2019

In 2019, David Gionco earned a total compensation of $1.4M as Senior Vice President of Finance and Chief Accounting Officer at Stemline Therapeutics, a 34% decrease compared to previous year.

Compensation breakdown

Bonus$184,928
Salary$342,460
Stock Awards$877,504
Total$1,404,892

Gionco received $877.5K in stock awards, accounting for 62% of the total pay in 2019.

Gionco also received $184.9K in bonus and $342.5K in salary.

Rankings

In 2019, David Gionco's compensation ranked 7,645th out of 13,971 executives tracked by ExecPay. In other words, Gionco earned more than 45.3% of executives.

ClassificationRankingPercentile
All
7,645
out of 13,971
45th
Division
Manufacturing
2,978
out of 5,701
48th
Major group
Chemicals And Allied Products
1,118
out of 2,200
49th
Industry group
Drugs
952
out of 1,886
50th
Industry
Pharmaceutical Preparations
706
out of 1,398
50th
Source: SEC filing on April 29, 2020.

Gionco's colleagues

We found three more compensation records of executives who worked with David Gionco at Stemline Therapeutics in 2019.

2019

Ivan Bergstein

Stemline Therapeutics

Chief Executive Officer

2019

Kenneth Hoberman

Stemline Therapeutics

Chief Operating Officer

2019

Robert Francomano

Stemline Therapeutics

Chief Commercial Officer

News

You may also like